DRUG: Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
Entry
D11382 Mixture Drug
Name
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide;
Symtuza (TN)
Product
SYMTUZA (Janssen Products LP)
Component
(Darunavir [DR:
D03656
] | Darunavir ethanolate [DR:
D06478
]), Cobicistat [DR:
D09881
], Emtricitabine [DR:
D01199
], (Tenofovir alafenamide [DR:
D10428
] | Tenofovir alafenamide fumarate [DR:
D10605
])
Remark
Therapeutic category:
6250
ATC code:
J05AR22
Product:
D11382<US>
Efficacy
Antiviral
Disease
HIV-1 infection [DS:
H01563
]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:
br08303
]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR22 Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
D11382 Darunavir, cobicistat, emtricitabine and tenofovir alafenamide <US>
USP drug classification [BR:
br08302
]
Antivirals
Anti-HIV Agents, Other
Darunavir/ Cobicistat/ Emtricitabine/ Tenofovir Alafenamide Fumarate
D11382 Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
Therapeutic category of drugs in Japan [BR:
br08301
]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D11382 Darunavir, cobicistat, emtricitabine and tenofovir alafenamide
New drug approvals in Europe [
br08329.html
]
European public assessment reports (EPAR) authorised medicine
D11382
Other DBs
PubChem:
384585360
LinkDB
» Japanese version
» Back
DBGET
integrated database retrieval system
